2003
DOI: 10.1097/00005344-200312001-00021
|View full text |Cite
|
Sign up to set email alerts
|

Transfer of Rabbit Autoimmune Cardiomyopathy into Severe Combined Immunodeficiency Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
10
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 25 publications
1
10
0
Order By: Relevance
“…19 -22 AA␤ARs have been induced in experimental animal models, are associated with the onset of cardiomyopathy, and have been passively transferred from either a human source or from animal models to produce a cardiomyopathy. [22][23][24] These characteristics fulfill the postulates of Witebsky et al 25 for proof of an autoimmune cardiomyopathy. A most difficult corollary is to remove the antibody and thereby demonstrate improvement and/or cure of the disease.…”
Section: Discussionsupporting
confidence: 60%
“…19 -22 AA␤ARs have been induced in experimental animal models, are associated with the onset of cardiomyopathy, and have been passively transferred from either a human source or from animal models to produce a cardiomyopathy. [22][23][24] These characteristics fulfill the postulates of Witebsky et al 25 for proof of an autoimmune cardiomyopathy. A most difficult corollary is to remove the antibody and thereby demonstrate improvement and/or cure of the disease.…”
Section: Discussionsupporting
confidence: 60%
“…Moreover, after 6 months of immunization the rabbits were found to develop LV-hypertrophy rather than LV-dilatation (as determined by echocardiography and histology) which was, however, no longer present after 12 months of immunization, perhaps indicating the transition into an early DCM-phenotype [40]. In the following time, (indirect) evidence for a pathogenic role of anti-β 1 -EC II has been supported further by the fact that intraperitoneal injection of blood lymphocytes either from immunized anti-β 1 -EC II -positive rabbits [50], or from anti-β 1 -AR-positive DCM patients [51] into immunodeficient mice -in order to avoid the expected immune reaction against rabbit or human non-self proteins -may lead to an early stage of cardiac dilatation. Nonetheless, direct evidence for a cause-andeffect relation between anti-β 1 -AR antibodies and DCM still remained to be established.…”
Section: Stimulatory Anti-β 1 -Ecii (Auto-)antibodies Are Pathogenicmentioning
confidence: 98%
“…The severe combined immunodeficiency mouse has been used to demonstrate a pathogenic role of peripheral blood leukocytes from patients with myocarditis (14) and dilated cardiomyopathy (15). Transfer of IgG and/or peripheral blood lymphocytes from rabbit autoimmune cardiomyopathy to severe combined deficiency mice has been shown to increase heart weight, blood brain natriuretic peptide and focal infiltration of inflammatory cells in the myocardium (16).…”
Section: Introductionmentioning
confidence: 99%